Stockreport

Gain Therapeutics to Present at Neuroscience 2025

Gain Therapeutics, Inc.  (GANX) 
PDF BETHESDA, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [Read more]